Cancer Cure? 10-Year Leukemia Remission Reported With Personalized T-Cell Therapy

Research results published in Nature this month demonstrate that chimeric antigen receptor (CAR) T-cell therapy, which uses engineered T-cells to target cancer, held leukemia at bay in two patients for at least 10 years. The patients — who both had chronic lymphocytic leukemia (CLL) — received the experimental therapy in 2010 and remained cancer-free for 10 years. One patient died in early 2021 from COVID-19 complications. The other is considered cured of cancer.